General
TGA chief says investigations likely to reveal more details about ‘atypical’ blood-clotting death
The head of the Therapeutic Goods Administration says an autopsy and review may reveal further information about a woman’s death from blood clotting likely linked to the AstraZeneca vaccine.
Key points:
- Professor Skerritt said the woman’s death was an “atypical” case
- The TGA said on Friday the fatal blood clotting was likely linked to the AstraZeneca vaccine
- The federal government is asking health authorities to continuously review all vaccines in the wake of the death
The 48-year-old woman from the New South Wales Central Coast had underlying health conditions but died in hospital several days after receiving the vaccine.
She received the AstraZeneca vaccine before authorities changed their advice to say people aged under 50 should…
Continue Reading
-
Business9 hours agoHow to retire in your 50s with ASX shares
-
General9 hours agoCoalition seeks to rebuild ties with Indian community
-
Noosa News12 hours agoOver $50K raised for Noosa’s Oz Bayldon after brain aneurysm
-
Noosa News11 hours agoNational Drought Forum convenes in SA to put policy under scrutiny